These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8140677)

  • 1. HLA antigens in Peyronie's disease.
    Rompel R; Mueller-Eckhardt G; Schroeder-Printzen I; Weidner W
    Urol Int; 1994; 52(1):34-7. PubMed ID: 8140677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA association of idiopathic Peyronie's disease: an indication of autoimmune phenomena in etiopathogenesis?
    Rompel R; Weidner W; Mueller-Eckhardt G
    Tissue Antigens; 1991 Sep; 38(3):104-6. PubMed ID: 1796451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there an immunogenetic basis for Peyronie's disease?
    Leffell MS
    J Urol; 1997 Jan; 157(1):295-7. PubMed ID: 8976283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-association of Peyronie's disease with HLA B7 cross-reactive antigens.
    Leffell MS; Devine CJ; Horton CE; Somers KD; Dawson D; Vande Berg JS; Bluemink GG; Wright GI
    J Urol; 1982 Jun; 127(6):1223-4. PubMed ID: 6979636
    [No Abstract]   [Full Text] [Related]  

  • 5. The genetic and bacteriological aspects of Peyronie's disease.
    Ralph DJ; Schwartz G; Moore W; Pryor JP; Ebringer A; Bottazzo GF
    J Urol; 1997 Jan; 157(1):291-4. PubMed ID: 8976282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an inherited form of Peyronie's disease with autosomal dominant inheritance and association with Dupuytren's contracture and histocompatibility B7 cross-reacting antigens.
    Nyberg LM; Bias WB; Hochberg MC; Walsh PC
    J Urol; 1982 Jul; 128(1):48-51. PubMed ID: 6980996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peyronie's disease is associated with an HLA class II antigen, HLA-DQ5, implying an autoimmune etiology.
    Nachtsheim DA; Rearden A
    J Urol; 1996 Oct; 156(4):1330-4. PubMed ID: 8808864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective analysis of HLA classes I and II antigen frequency in patients with Peyronie's disease.
    Hauck EW; Hauptmann A; Weidner W; Bein G; Hackstein H
    J Urol; 2003 Oct; 170(4 Pt 1):1443-6. PubMed ID: 14501786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peyronie's disease: a newly recognized autosomal-dominant trait.
    Bias WB; Nyberg LM; Hochberg MC; Walsh PC
    Am J Med Genet; 1982 Jun; 12(2):227-35. PubMed ID: 6213155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of Peyronie's disease with HLA B7 cross-reactive antigens. A case report of identical twins.
    Ziegelbaum M; Thomas A; Zachary AA
    Cleve Clin J Med; 1987; 54(5):427-30. PubMed ID: 3499260
    [No Abstract]   [Full Text] [Related]  

  • 11. The genetics and immunology of Peyronie's disease.
    Noss MB; Day NS; Christ GJ; Melman A
    Int J Impot Res; 2000 Oct; 12 Suppl 4():S127-32. PubMed ID: 11035400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-A and B antigens in patients with Peyronie disease.
    Deguchi T; Maeda S; Sakai S; Kuriyama M; Kawada Y; Nishiura T
    Urology; 1984 Jun; 23(6):547-8. PubMed ID: 6587656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of histocompatibility antigens of the B7 cross-reacting group with Peyronie's disease.
    Willscher MK; Cwazka WF; Novicki DE
    J Urol; 1979 Jul; 122(1):34-5. PubMed ID: 458986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HLA typing and insulin antibody production in insulin-dependent diabetics].
    Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
    Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunological features of Peyronie's disease.
    Ralph DJ; Mirakian R; Pryor JP; Bottazzo GF
    J Urol; 1996 Jan; 155(1):159-62. PubMed ID: 7490821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of HLA molecules to Dupuytren's contracture in a Southeast Brazilian population.
    Usó SM; Sanson AC; Covolo-Santana Fde S; Marcos EV; Marques T; Cury Filho M; Ura S
    Rev Bras Reumatol; 2014; 54(1):38-43. PubMed ID: 24878790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture.
    Sampaio FJ
    Int Braz J Urol; 2004; 30(4):349-50. PubMed ID: 15679983
    [No Abstract]   [Full Text] [Related]  

  • 18. HLA antigens in Italian patients with systemic lupus erythematosus: evidence for the association of DQw2 with the autoantibody response to extractable nuclear antigens.
    Lulli P; Sebastiani GD; Trabace S; Passiu G; Cappellacci S; Porzio F; Morellini M; Cutrupi F; Galeazzi M
    Clin Exp Rheumatol; 1991; 9(5):475-9. PubMed ID: 1954698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors.
    Donaldson PT; Doherty DG; Hayllar KM; McFarlane IG; Johnson PJ; Williams R
    Hepatology; 1991 Apr; 13(4):701-6. PubMed ID: 2010165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human leukocyte antigens and multiple basal cell carcinomas.
    Rompel R; Petres J; Kaupert K; Müller-Eckhardt G
    Recent Results Cancer Res; 1995; 139():297-302. PubMed ID: 7597298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.